C07C 55/12
Glutaric acid
C07C55/12 (Glutaric acid) appears on 26 US grants and 38 published applications in this corpus.
Search patents in C07C- Granted patents
- 26
- Published applications
- 38
- Assignees
- 40
- Inventors
- 157
- Latest grant
- 15 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 1 | 1 |
| 2012 | 2 | 3 |
| 2013 | 2 | 3 |
| 2014 | 1 | 2 |
| 2015 | 2 | 2 |
| 2016 | 1 | 3 |
| 2017 | 2 | 2 |
| 2018 | 3 | 2 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 0 | 0 |
| 2023 | 0 | 5 |
| 2024 | 0 | 3 |
| 2025 | 2 | 2 |
| 2026 | 0 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Berberine alpha-ketoglutarate salt, crystalline form, methods of preparation and applications thereof15 Jul 2025US 12,358,922 B1Longevitan Biosciences LLC
- Polymorphs of phenyl pyrrole aminoguandium salts4 Mar 2025US 12,239,631 B2Synact Pharma APS
- Polymorphic forms and co-crystals of a c-Met inhibitor9 Jul 2019US 10,344,041 B2Amgen Inc.
- Cocrystalline DHEA formulations20 Nov 2018US 10,130,713 B2The Methodist Hospital
- Polymorphic forms and co-crystals of a c-Met inhibitor29 May 2018US 9,981,988 B2Amgen Inc.
- Ulodesine salt24 Sep 2026US 2026/0285864 A1Laevoroc Immunology AG
- Ulodesine salt27 Aug 2026US 2026/0250293 A1Laevoroc Immunology AG
- Semiconductor photoresist composition and method of forming patterns using the composition11 Jun 2026US 2026/0161071 A1Samsung SDI.Co., Ltd.
- Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amine7 May 2026US 2026/0125345 A1
- Crystalline salt forms of n-((1-(2-(tert-butylamino)-2-oxoethyl)piperidin-4-yl) methyl)-3-chloro-5-fluorobenzamide and methods of use thereof2 Apr 2026US 2026/0092037 A1Praxis Precision Medicines, Inc.
Most cited
By later US patents
- Photodecomposable bases and photoresist compositions470US 8,614,047 B2International Business Machines Corporation · 2013
- Method for production of ultra-fine gold particle-immobilized oxides30US 5,051,394 AAgency of Industrial Science and Technology · 1991
- Method for extracting tobacco alkaloids27US 5,119,835 AB.A.T. Cigarettenfabriken GmbH · 1992
- Salts of dasatinib in amorphous form18US 9,884,857 B2BASF SE · 2018
- Catalyst for the copolymerization of epoxides with CO.sub.215US 5,026,676 AAir Products and Chemicals, Inc. · 1991